Carcinoembryonic Antigen Peptide 1-6D

Preferred Label : Carcinoembryonic Antigen Peptide 1-6D;

NCIt synonyms : Modified CEA Peptide; CEA:571-579 (576D); mCEA Peptide; CAP-1-6D Peptide; CEA 571-579 Peptide;

NCIt definition : A 9-residue human leukocyte antigen (HLA)-restricted fragment of carcinoembryonic antigen (CEA). Vaccination with carcinoembryonic antigen peptide 1-6D, which has the amino acid sequence YLSGANLNL, may elicit a cytotoxic T lymphocyte (CTL) immune response against tumors expressing CEA.;

NSC code : 701524;

Details

Origin ID

C2622;

UMLS CUI

C0935801;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_affects_cell_type_or_tissue
- Cytotoxic T-Lymphocyte [NCIt concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Sensitization [NCIt concept]
chemical_or_drug_has_physiologic_effect
- Immunopotentiation [NCIt concept]
- T-Cell Activation [NCIt concept]
concept_is_in_subset
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]
has_target
- Carcinoembryonic Antigen [NCIt concept]
is_component_of_chemotherapy_regimen
- Autologous Dendritic Cells/Carcinoembryonic Antigen Peptide 1-6D/CMV Pp65 Peptide [NCIt concept]
- Carcinoembryonic Antigen Peptide 1-6D/Montanide ISA-51 [NCIt concept]
- Carcinoembryonic Antigen Peptide 1-6D/Sargramostim [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients